返回
Basilea Pharmaceutica AG（BPMUF）價格
BPMUF 股價走勢圖
BPMUF 收益
Basilea Pharmaceutica AG
$72.66
5.38%
$3.7
收盤價：Jan 27, 16:00:00 GMT-5
$72.66
0%
$0
盤後：Jan 27, 19:37:14 GMT-5
關鍵數據
前收市價
$68.95
開盤價
$67.66
當日範圍
$67.66 - $72.66
52週區間
$47.5 - $72.66
交易量
5
平均成交量
9
每股盈餘 (TTM)
6.94
股息收益率
--
市值
$891.5M
什麼是 BASILEA PHARMACEUTICA AG ALLSCH？
Basilea Pharmaceutica AG engages in the development and commercialization of pharmaceutical products. The company is headquartered in Allschwil, Basel-Landschaft and currently employs 180 full-time employees. The company went IPO on 2004-03-25. The firm operates in one segment, which is the discovery, development, and commercialization of pharmaceutical products to meet the needs of patients with severe bacterial and fungal infections. The company launched two hospital brands, Cresemba, which is an intravenous and oral drug for the treatment of invasive fungal infections, and Zevtera, which is an intravenous antibiotic for the treatment of severe bacterial infections, especially pneumonia. Additionally, the Company has several preclinical anti-infective assets in their portfolio. Company's products are present in United States, Canada, Europe, Asia, and Africa.